Oxidative stress and C-reactive protein in patients with cerebrovascular accident (Ischaemic Stroke): The role of Ginkgo biloba extract

Sultan Qaboos University Medical Journal

Volumn 12, Issue 2, 2012, Pages 197-205

  Thanoon, Imad A J ^a   Abdul Jabbar, Hilmy A S ^b   Taha, Dhia A ^c  

^a UNIVERSITY OF MOSUL   (Iraq)

^b Iben Seena Hospital   (Iraq)

^c Salah Al Din Health Institute   (Iraq)

Author keywords

Antioxidant; C reactive protein; Cerebrovascular accident; Ginkgo biloba; Iraq; Ischaemia; Malondialdehyde; Oxidative stress; Stroke

Indexed keywords

GINKGO BILOBA;

EID: 84859825914     PISSN: 2075051X     EISSN: 20750528     Source Type: Journal    
DOI: 10.12816/0003113     Document Type: Article

References (56)

1. Thorvaldsen P, Kuulasmaa K, Rajakangas A, Rastenyte D, Sarti C, Wilhelmsen L. Stroke trends in the WHO MONICA project. Stroke 1997; 28:500-6.
2. World Health Organization. The World Health Report (2003): Shaping the Future. Geneva: World Health Organization, 2003.
3. Kidd PM. Integrated brain restoration after ischemic stroke - medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain plasticity. Altern Med Rev 2009; 14:14-35.
4. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003; 4:399-415.
5. Iadecola C, Cho S, Feuerstein GZ, Hallenbeck J. Cerebral Ischemia and Inflammation. In: Wolf P, Ed. Stroke: Pathophysiology, Diagnosis, and Management. New York: Churchill Livingstone, 2004. Pp. 883-94.
6. Giulian D. Reactive Microglia and Ischemic Injury. In: Weir, B, Ed. Primer on Cerebrovascular Diseases. San Diego: Academic, 1997. Pp. 117-124.
7. Schwartz M. Macrophages and microglia in central nervous system injury: are they helpful or harmful? J Cereb Blood Flow Metab 2003; 23:385-94.
8. Sudha K, Rao AV, Rao SN, Rao A. Oxidative damage and plasma antioxidants in cerebrovascular accident. Indian J Physiol Pharmacol 2004; 48:489-92.
9. Lopez E, Illnait J, Molina V, Oyarzabal A, Fernandez L, Perez Y, et al. Effects of D-002 (beeswax alcohols) on lipid peroxidation in middle-aged and older subjects. Lat Am J Pharm 2008; 27:695-703.
10. Gariballa SE, Hutchin TP, Sinclair AJ. Antioxidant capacity after acute ischemic stroke. 2002; 95:685-90.
11. Ryan M, Grayson L, Clarke DJ. The total antioxidant capacity of human serum measured using enhanced chemiluminescence is almost completely accounted for by urate. Ann Clin Biochem 1997; 34:688-9.
12. Mishra PT, Chandra R, Saxena SK, Verma S, Jain R, Bhuyan A. H sensitivity C-reactive protein (hsCRP) level in cerebrovascular accident (stroke). JIACM 2010; 11:204-7.
13. Elkind MS. Inflammation, atherosclerosis, and stroke. Neurologist 2006; 12:140-8.
14. Ramos AM, Pellanda LC, Gus I, Portal VL. Inflammatory markers of cardiovascular disease in the elderly. Arq Bras Cardiol 2009; 92:221-8.
15. Di Napoli M, Di Gianfilippa G, Sollecito A, Bocola V. C-reactive protein and outcome after first-ever ischemic stroke. Stroke 2000; 31:238-9.
16. Ford ES, Giles WH. Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey. Arterioscler Thromb Vasc Biol 2000; 20:1052-6.
17. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-43.
18. Winbeck K, Kukla C, Poppert H, Klingelhofer J, Conrad B, Sander D. Elevated C-reactive protein is associated with an increased intima to media thickness of the common carotid artery. Cerebrovasc Dis 2002; 13:57-63.
19. Oyama Y, Chikahisa L, Ueha T, Kanemaru K, Noda K. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res 1996; 712:349-52.
20. Xin W, Wei T, Chen C, Ni Y, Zhao B, Hou J. Mechanisms of apoptosis in rat cerebellar granule cells induced by hydroxyl radicals and the effect of EGb761 and its constituents. Toxicology 2000; 148:103-10.
21. da Silva GGP, Zanoni JN, Buttow NC. Neuroprotective action of Ginkgo biloba on the enteric nervous system of diabetic rats. World J Gastroenterol 2011; 17: 898-905.
22. Ni Y, Zhao B, Hou J, Xin W. Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicals. Neurosci Lett 1996; 214:115-8.
23. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008; 585:325-37.
24. Smith PF, MacLennan CL, Darlington J. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacol 1996; 50:131-9.
25. Buege JA, Aust SD. Thiobarbuturic acid assay. Methods Enzymol 1978; 52:306-7.
26. Traystamn RJ, Kirsch JR, Koehler RC. Oxygen radical mechanism of brain injury following ischaemia and reperfusion. J Appl Physiol 1991; 71:1185-95.
27. White BC, Daya A, DeGracia DJ, O'Neil BJ, Skjaerlund JM, Trumble S. Fluorescent histochemical localization of lipid peroxidation during brain reperfusion following cardiac arrest. Acta Neuropathol (Berl) 1993; 86:1-9.
28. Alexandrova ML, Bochev PG. Oxidative stress during the chronic phase after stroke. Free Radic Biol Med 2005; 39:297-316.
29. Flohe L, Beckmann R, Giertz H, Loschen G. Oxygen-Centered Free Radicals as Mediators of Inflammation. In: Sies H, Ed. Oxidative Stress. London: Academic Press, 1985. Pp. 403-36.
30. Marnett LJ. Oxy radicals, lipid peroxidation and DNA damage. Toxicology 2002; 27:181-2, 219-22.
31. Gawel S, Wardas M, Niedworok E, Wardas P. Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad Lek 2004; 57:453-5.
32. Yildirim A, Kotan D, Yildirim S, Aygul R, Akcay F. Increased lipid peroxidation and decreased antioxidant response in serum and cerebrospinal fluid in acute ischemic stroke. Turk J Med Sci 2007; 37:75-81.
33. Aygul R, Kotan D, Yildirim A, Ulvi H, Akcay F. Plasma and cerebrospinal fluid homocysteine, nitric oxide and malondialdehyde in acute ischemic stroke: possible role of free radicals in the development of brain injury. Eur J Gen Med 2008; 5:57-63.
34. Leionen JS, Ahonen JP, Lonrot K, Jehkonen M, Dastidar P, Molnar G, Alho H. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke 2000; 31:33-9.
35. Cherubini A, Polidori MC, Bregnachi M, Pezzuto S, Cecchetti RBS, Ingegni T, et al. Antioxidant profile and early outcome in stroke patients. Stroke 2000; 31:2295-2300.
36. Santos MD, Valles J, Aznar J, Vilches J. Determination of plasma malondialdehyde-like material and its clinical application in stroke patients. J Clin Pathol 1980; 33:973-6.
37. El Kossi MMH, Zakhary MM. Oxidative stress in the context of acute cerebrovascular stroke. Stroke 2000; 31:1889-92.
38. Al-Rawi NH. Salivary lipid peroxidation and lipid profile levels in patients with recent ischemic stroke. J Int Dent Med Res 2010; 3:57-64.
39. Jawalekar SL, Kulkarni UJ, Surve VT, Deshmukh YA. Status of lipid profile, MDA and protein carbonyl in patients with cardiovascular diseases. Arch Appl Sci Res 2010; 2:8-14.
40. Bir LS, Demir S, Rota S, Koseoglu M. Increased serum malodialdehyde levels in chronic stage of ischemic stroke. Tohoku J Exp Med 2006; 208:33-9.
41. Sanchez-Moreno C, Dashe JF, Scott T, Thaler D, Folstein MF, Martin A. Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 2004; 35:163-8.
42. Gruener N, Gross B, Gozlan O, Barak M. Increase in superoxide dismutase after cerebrovascular accident. Life Sci 1994; 54:711-13.
43. Adachi T, Nakamura M, Yamada H, Futenma A, Kato K, Hirano K. Quantitative and qualitative changes of extracellular-superoxide dismutase in patients with various diseases. Clin Chim Acta 1994; 229:123-31.
44. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973-9.
45. Koenig W, Pepys MB. C-reactive protein risk prediction: low specificity, high sensitivity. Ann Intern Med 2002; 136:550-2.
46. Barone FC, Feuerstein GZ. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 1999; 19:819-34.
47. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002; 33:2459-64.
48. Jurcau A. The role of antioxidant treatment in acute ischemic stroke: a clinical study. Romanian J Neurol 2007; 6:181-8.
49. Zeybek N, Gorgulu S, Yagci G, Serdar M, Simsek A, Kaymakcioglu N, et al. The effect of Gingko biloba extract (EGb 761) on experimental acute pancreatitis. J Surg Res 2003; 15:286-93.
50. Bridi R, Crosseti FP, Steffen VM, Henriques AT. The antioxidant activity of standardized extract of Gingko biloba (EGb 761) in rats. Phytother Res 2001; 15:449.
51. Chen C, Wei TT, Gao ZH, Zhao BL, Hou JW, Xu HB, et al. Different effects of the constituents of EGb 761 on apoptosis in rat cerebellar granule cells induced by hydroxyl radicals. Biochem Mol Biol Int 1999; 47:397-405.
52. Zhang Y, Yu Q, You S, Sheng L. Ginkgolies protects the cultured rat cortical cells against metabolic, excitotoxic and oxidative insults. J Health Sci 2004; 50:348-55.
53. Morioka T, Kalehua AN, Streit WJ. The microglial reaction in the rat dorsal hippocampus following transient forebrain. J Cereb Blood Flow Metab 1991; 11:966-73.
54. Korematsu K, Goto S, Nagahiro S, Ushio Y. Microglial response to transient focal cerebral ischemia: an immunochemical study on the rat cerebral cortex using anti-phosphotysine antibody. J Cereb Blood Flow Metab 1994; 14:825-30.
55. Saleem S, Zhuang H, Biswal S. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 2008; 39:3389-96.
56. Butterfield DA, Castegna A, Pocernich CB, Drake J, Scapagnini G, Calabrese V. Nutritional approaches to combat oxidative stress in Alzeimer's disease. J Nutr Biochem 2002; 13:444-61.